Unknown

Dataset Information

0

Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL.


ABSTRACT: Dietary fat-derived lipid oleoylethanolamide (OEA) has shown to modulate lipid metabolism through a peroxisome proliferator-activated receptor-alpha (PPAR-?)-mediated mechanism. In our study, we further demonstrated that OEA, as an atheroprotective agent, modulated the atherosclerotic plaques development. In vitro studies showed that OEA antagonized oxidized LDL (ox-LDL)-induced vascular endothelial cell proliferation and vascular smooth muscle cell migration, and suppressed lipopolysaccharide (LPS)-induced LDL modification and inflammation. In vivo studies, atherosclerosis animals were established using balloon-aortic denudation (BAD) rats and ApoE(-/-) mice fed with high-caloric diet (HCD) for 17 or 14 weeks respectively, and atherosclerotic plaques were evaluated by oil red staining. The administration of OEA (5 mg/kg/day, intraperitoneal injection, i.p.) prevented or attenuated the formation of atherosclerotic plaques in HCD-BAD rats or HCD-ApoE(-/-) mice. Gene expression analysis of vessel tissues from these animals showed that OEA induced the mRNA expressions of PPAR-? and downregulated the expression of M-CFS, an atherosclerotic marker, and genes involved in oxidation and inflammation, including iNOS, COX-2, TNF-? and IL-6. Collectively, our results suggested that OEA exerted a pharmacological effect on modulating atherosclerotic plaque formation through the inhibition of LDL modification in vascular system and therefore be a potential candidate for anti-atherosclerosis drug.

SUBMITTER: Fan A 

PROVIDER: S-EPMC3896367 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL.

Fan Angran A   Wu Xiaofeng X   Wu Huijuan H   Li Long L   Huang Rui R   Zhu Yueyong Y   Qiu Yan Y   Fu Jin J   Ren Jie J   Zhu Chenggang C  

PloS one 20140120 1


Dietary fat-derived lipid oleoylethanolamide (OEA) has shown to modulate lipid metabolism through a peroxisome proliferator-activated receptor-alpha (PPAR-α)-mediated mechanism. In our study, we further demonstrated that OEA, as an atheroprotective agent, modulated the atherosclerotic plaques development. In vitro studies showed that OEA antagonized oxidized LDL (ox-LDL)-induced vascular endothelial cell proliferation and vascular smooth muscle cell migration, and suppressed lipopolysaccharide (  ...[more]

Similar Datasets

| S-EPMC4773867 | biostudies-other
| S-EPMC3773831 | biostudies-other
| S-EPMC4174006 | biostudies-literature
| S-EPMC2783367 | biostudies-literature
| S-EPMC8616354 | biostudies-literature
| S-EPMC2631098 | biostudies-literature
2024-02-12 | GSE251637 | GEO
| S-EPMC4109759 | biostudies-literature
| S-EPMC5407291 | biostudies-literature
| S-EPMC11308466 | biostudies-literature